Siegfried Hekimi
Corporate Officer/Principal chez McGill University
Profil
Siegfried Hekimi is the founder of Chronogen, Inc. which was founded in 1998.
He held the title of Chief Scientific Officer from 2009 to 2010.
Currently, he is a Professor at McGill University.
Dr. Hekimi obtained a doctorate degree from the University of Geneva.
Postes actifs de Siegfried Hekimi
| Sociétés | Poste | Début |
|---|---|---|
| McGill University | Corporate Officer/Principal | - |
Anciens postes connus de Siegfried Hekimi
| Sociétés | Poste | Fin |
|---|---|---|
Chronogen, Inc.
 Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Fondateur | 23/04/2010 |
Formation de Siegfried Hekimi
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Health Technology |
